We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QMCO icon
976
Quantum Corp
QMCO
$917M
$1.02M ﹤0.01%
9,080
+643
+8% +$69.2K
FMC icon
977
FMC
FMC
$1.41B
$1.02M ﹤0.01%
12,377
+1,153
+10% +$92.7K
A icon
978
Agilent Technologies
A
$42.4B
$1.01M ﹤0.01%
15,141
+54
+0.4% +$3.64K
CAI
979
DELISTED
CAI International, Inc.
CAI
$997K ﹤0.01%
35,200
+18,200
+107% +$601K
OSB
980
DELISTED
Norbord Inc.
OSB
$997K ﹤0.01%
29,500
+15,500
+111% +$555K
SLCA
981
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$977K ﹤0.01%
30,000
-93,394
-76% -$2.98M
ENS icon
982
EnerSys
ENS
$6.15B
$975K ﹤0.01%
14,000
+600
+4% +$41.1K
BPMC
983
DELISTED
Blueprint Medicines
BPMC
$965K ﹤0.01%
12,800
+3,300
+35% +$232K
AVT icon
984
Avnet
AVT
$7.6B
$959K ﹤0.01%
24,200
+1,200
+5% +$48K
VTLE
985
DELISTED
Vital Energy
VTLE
$959K ﹤0.01%
4,519
-1,400
-24% -$307K
KB icon
986
KB Financial Group
KB
$45.5B
$955K ﹤0.01%
16,321
PKX icon
987
POSCO
PKX
$18.5B
$953K ﹤0.01%
12,196
-966
-7% -$71.4K
COKE icon
988
Coca-Cola Consolidated
COKE
$13.2B
$947K ﹤0.01%
44,000
-54,000
-55% -$1.18M
STE icon
989
Steris
STE
$20.5B
$942K ﹤0.01%
10,770
LUMN icon
990
Lumen
LUMN
$7.04B
$940K ﹤0.01%
56,323
+11,889
+27% +$202K
SHG icon
991
Shinhan Financial Group
SHG
$38.8B
$938K ﹤0.01%
20,214
XSLV icon
992
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
$935K ﹤0.01%
20,220
-2,200
-10% -$103K
LBTYK icon
993
Liberty Global Class C
LBTYK
$3.44B
$934K ﹤0.01%
27,591
DVA icon
994
DaVita
DVA
$12.2B
$932K ﹤0.01%
+12,900
New +$794K
CRTO icon
995
Criteo S.A.
CRTO
$837M
$931K ﹤0.01%
35,765
SHY icon
996
iShares 1-3 Year Treasury Bond ETF
SHY
$26B
$928K ﹤0.01%
11,063
-1,690
-13% -$142K
PDLI
997
DELISTED
PDL BioPharma, Inc.
PDLI
$928K ﹤0.01%
338,800
+318,100
+1,537% +$977K
KVHI icon
998
KVH Industries
KVHI
$130M
$927K ﹤0.01%
89,541
SAIC icon
999
Saic
SAIC
$5.6B
$927K ﹤0.01%
12,105
NWLI
1000
DELISTED
National Western Life Group, Inc. Class A
NWLI
$927K ﹤0.01%
2,800
+100
+4% +$34.9K

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.